The association of pathological nuchal translucency to placental complications in cases of normal microarray analysis

被引:0
|
作者
Krispin, Eyal [1 ]
Kushnir, Anya [2 ]
Shemer, Assaf [3 ]
Rienstein, Shlomit [2 ]
Berekendt, Michal [2 ]
Yinon, Yoav [2 ]
Weisz, Boaz [2 ]
机构
[1] Women Hosp, Rabin Med Ctr, Petah Tiqwa, Israel
[2] Sheba Med Ctr, Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
关键词
D O I
10.1016/j.ajog.2019.11.120
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
104
引用
收藏
页码:S84 / S85
页数:2
相关论文
共 38 条
  • [21] Nuchal translucency of 3.0-3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review
    Petersen, Olav B.
    Smith, Eric
    Van Opstal, Diane
    Polak, Marike
    Knapen, Maarten F. C. M.
    Diderich, Karin E. M.
    Bilardo, Caterina M.
    Arends, Lidia R.
    Vogel, Ida
    Srebniak, Malgorzata, I
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2020, 99 (06) : 765 - 774
  • [22] Nuchal translucency, ductus venosus and congenital heart disease: an important association - a cautious analysis
    Carvalho, JS
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1999, 14 (05) : 302 - 306
  • [23] Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta-analysis
    Sotiriadis, A.
    Papatheodorou, S.
    Eleftheriades, M.
    Makrydimas, G.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 42 (04) : 383 - 389
  • [24] Increased nuchal translucency with normal karyotype: a follow-up study of 100 cases supplemented with CGH and MLPA analyses
    Schou, K. V.
    Kirchhoff, M.
    Nygaard, U.
    Jorgensen, C.
    Sundberg, K.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2009, 34 (06) : 618 - 622
  • [25] Risk of Clinically Significant Chromosomal Microarray Analysis Findings in Fetuses With Nuchal Translucency From 3.0 mm Through 3.4 mm
    Sagi-Dain, Lena
    Singer, Amihood
    Ben Shachar, Shay
    Josefsberg Ben Yehoshua, Sagi
    Feingold-Zadok, Michal
    Greenbaum, Lior
    Maya, Idit
    OBSTETRICS AND GYNECOLOGY, 2021, 137 (01): : 126 - 131
  • [26] Do maternal characteristics affect nuchal translucency variation?: Analysis of five million cases from NTQR Program
    Dugoff, Lorraine
    Cuckle, Howard
    Platt, Lawrence D.
    Fuchs, Karin
    McIntosh, Jennifer
    Toland, Gregory J.
    Bromley, Bryann
    Thornburg, Loralei L.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S83 - S84
  • [27] Microarray analysis of differentially expressed genes in preeclamptic and normal placental tissues
    Ma, K.
    Lian, Y.
    Zhou, S.
    Hu, R.
    Xiong, Y.
    Ting, P.
    Xiong, Y.
    Li, X.
    Wang, X.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2014, 41 (03): : 261 - 271
  • [28] Correlation Analysis of the EEG Signals in Normal and Pathological Cases
    Stanciu, Nicolae Stelian
    2021 12TH INTERNATIONAL SYMPOSIUM ON ADVANCED TOPICS IN ELECTRICAL ENGINEERING (ATEE), 2021,
  • [29] SERUM HUMAN PLACENTAL LACTOGEN IN CASES OF NORMAL AND PATHOLOGICAL PREGNANCIES IN COMPARISON TO OTHER ENDOCRINE PARAMETERS
    BELLMANN, O
    PATT, V
    LEYENDEC.G
    NOCKE, W
    ARCHIV FUR GYNAKOLOGIE, 1973, 214 (1-4): : 443 - 445
  • [30] First-trimester nuchal translucency and cystic hygroma: a risk a risk analysis on fetal chromosome abnormality; a report on 183 cases.
    Saura, R
    Lechat, X
    Taine, L
    Wen, ZQ
    Guyon, F
    Horovitz, J
    CYTOGENETICS AND CELL GENETICS, 1997, 77 (1-2): : W81 - W81